![]() |
|
|
Vol. 28, Issue 2, 180-185, February 2000
Department of Toxicology, Institute of Pharmacology and Toxicology,
University of Göttingen, Göttingen, Germany (E.Schrader,
K.I.H.-E., E.Scholz, G.F.K.); and Institute of Environmental
Toxicology, University of Halle-Wittenberg, Halle, Germany (H.F.).
The tobacco-specific nitrosamine
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) induces primarily
lung tumors, which are assumed to derive from malignant transformation
of alveolar type II (AII) cells within the lung. To elicit its
carcinogenic effects, NNK requires metabolic activation by cytochrome
P-450 (CYP)-mediated
-hydroxylation. Therefore, in this study the
metabolism of NNK and expression of the NNK-activating CYP isoform
CYP2B1 were investigated in primary cultures of rat AII cells. Although basal expression of CYP2B1 decreased in a time-dependent manner during
culture of AII cells, substantial CYP2B1 protein expression was
observed in AII cell cultures after the first 24 h. When AII cells
were incubated with 0.05 µM [5-3H]NNK,
N-oxidation of NNK, which is thought to represent a
detoxification pathway, was predominant (42%).
-Hydroxylated
metabolites resulting from metabolic activation of NNK amounted to 35%
of all detected metabolites. However, the proportion of
-hydroxylated metabolites decreased to 17% of all detected
metabolites when AII cells were incubated with a 100-fold higher
concentration of NNK (5 µM). In summary, this study indicates
a remarkable activity of cultured AII cells to metabolize NNK, leading
to substantial metabolic activation of NNK, which was more pronounced
in incubations at low NNK concentration. Because exposure to NNK via
cigarette smoking is thought to lead to very low plasma NNK
concentrations (1-15 pM), these data suggest that metabolic activation
of NNK in cigarette smokers might occur to a larger extent than would
be expected according to previous metabolic studies performed with high
(micromolar) NNK concentrations.
This article has been cited by other articles:
![]() |
X.-Y. He, J. Shen, X. Ding, A. Y. H. Lu, and J.-Y. Hong IDENTIFICATION OF CRITICAL AMINO ACID RESIDUES OF HUMAN CYP2A13 FOR THE METABOLIC ACTIVATION OF 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE, A TOBACCO-SPECIFIC CARCINOGEN Drug Metab. Dispos., December 1, 2004; 32(12): 1516 - 1521. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-I. Proulx, A. Castonguay, and E. Y. Bissonnette Cytokine production by alveolar macrophages is down regulated by the {alpha}-methylhydroxylation pathway of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) Carcinogenesis, June 1, 2004; 25(6): 997 - 1003. [Abstract] [Full Text] [PDF] |
||||